Navigation Links
Peregrine Pharmaceuticals Completes Planned Patient Enrollment in Bavituximab Phase I Cancer Trial
Date:6/30/2009

- Completion of Phase I Paves Way for Expanding Bavituximab Cancer Program -

- Inclusion of Patients with Diverse Advanced Cancers Along with Promising Interim Phase II Data Suggest Bavituximab Could Have Broad Anti-Cancer Utility -

TUSTIN, Calif., June 30 /PRNewswire-FirstCall/ -- Peregrine Pharmaceuticals, Inc. (Nasdaq: PPHM) today announced that it has completed the planned patient enrollment in its U.S. Phase I clinical trial evaluating bavituximab as monotherapy in patients with advanced refractory cancers. In a presentation of preliminary data from this trial at the 2009 ASCO Annual Meeting last month, the study's principal investigator at MD Anderson Cancer Center reported that bavituximab was generally safe and well-tolerated, with a predictable pharmacokinetic profile. In these patients, a maximum tolerated dose had not been reached even at the highest planned dose level. Peregrine has now begun designing additional bavituximab cancer trials based on findings from this Phase I study and the company's ongoing Phase II combination therapy trials in breast and lung cancer.

"Completion of patient enrollment in this Phase I trial is a significant milestone for the bavituximab cancer program," said Joseph Shan, vice president of clinical and regulatory affairs at Peregrine. "We believe data from this study, along with our ongoing Phase II lung and breast cancer trials, set the stage for advancing the bavituximab oncology program into later-stage clinical studies. The safety data collected from the diverse cancer types in this study are encouraging as we plan for expansion of the bavituximab cancer program in the coming year. We look forward to sharing more data from the ongoing cancer trials as patient treatment and follow-up continue in this study and in our three ongoing Phase II bavituximab cancer tri
'/>"/>

SOURCE Peregrine Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine news :

1. Positive Results From Peregrine Pharmaceuticals Bavituximab Phase l HCV Trial Presented at AASLD Meeting
2. Peregrine Pharmaceuticals Receives Approval to Begin New Phase II Trial of Bavituximab in Patients With Metastatic Breast Cancer
3. Peregrine Pharmaceuticals Announces Positive Data From Cotara(R) Brain Cancer Trials
4. Data Published in Nature Medicine Highlights Ability of Peregrine Pharmaceuticals Bavituximab to Cure Lethal Virus Infections
5. Peregrine Pharmaceuticals Awarded Broad New U.S. Patent for Anti-Viral Applications of Phospholipid-Targeting Antibodies
6. Peregrine Pharmaceuticals Reports Financial Results for the Second Quarter of Fiscal Year 2009
7. Peregrine Pharmaceuticals Bavituximab Achieves Primary Endpoint in First Stage of Phase II Breast Cancer Study
8. Peregrine Pharmaceuticals to Report Third Quarter FY 2009 Financial Results
9. Peregrine Pharmaceuticals Receives Additional Time to Regain Compliance With NASDAQs Minimum Bid Price Rule
10. Peregrine Pharmaceuticals Reports Progress in Cotara(R) Brain Cancer Clinical Program
11. ASCO Research Foundation Grant Will Support Study of Peregrines Bavituximab in Lung Cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/30/2015)... ... June 30, 2015 , ... Micro Com Systems ... high quality record management services for patient records. Medical imaging includes services such ... physicians and clinics. , With the increase in the acceptance level of ...
(Date:6/30/2015)... ... 2015 , ... Harbor Village Detox is a drug and ... on June 12th. Holly Vasquez-Cortella was recently quoted as an expert in the addiction ... on trending addiction news and treatment innovations. The article highlights Florida governor Rick Scott’s ...
(Date:6/30/2015)... , ... June 30, 2015 , ... Due to today’s housing market, many people cannot ... difficult as they have to make adjustments as to how to carry laundry or groceries ... have laundry facilities in the basement or first floor of the home, and the bedrooms ...
(Date:6/30/2015)... ... June 30, 2015 , ... Experts estimate that up to 80% of ... can range from a dull, constant ache (chronic) to a sudden sharp pain (acute). ... injections, selective nerve root blocks and rhizotomy treatment, OPTIMAL Pain & Regenerative Medicine ...
(Date:6/30/2015)... ... June 30, 2015 , ... New Xarelto lawsuit claims proposed ... of new forms, according to attorneys handling Xarelto lawsuits included in ... Complaint, “provide guidance” for plaintiffs’ attorneys in filing new claims, according to court ...
Breaking Medicine News(10 mins):Health News:Micro Com Systems Ltd Now Specializes in Medical Imaging 2Health News:Harbor Village Detox’s Clinical Director Is Quoted as an Addiction Expert by The Fix 2Health News:Harbor Village Detox’s Clinical Director Is Quoted as an Addiction Expert by The Fix 3Health News:Butler Mobility Products announce a Solution to Carry Items from One Floor to the Next with a Dumbwaiter 2Health News:OPTIMAL Pain & Regenerative Medicine Brings Innovative Back Pain Management Options Including PRP Injections and Stem Cell-like Therapies to Dallas/Ft. Worth Metroplex 2Health News:OPTIMAL Pain & Regenerative Medicine Brings Innovative Back Pain Management Options Including PRP Injections and Stem Cell-like Therapies to Dallas/Ft. Worth Metroplex 3Health News:Xarelto Lawsuit News: New Xarelto Lawsuit Filings to Be Expedited 2Health News:Xarelto Lawsuit News: New Xarelto Lawsuit Filings to Be Expedited 3
... in lab study , THURSDAY, Nov. 12 (HealthDay News) -- ... promise as a possible treatment for ovarian cancer, new research ... treat chronic myeloid leukemia. Researchers at the University of California ... and invasive powers of ovarian cancer cells. , It ...
... ... actuator. The IDEA Drive is an integrated linear actuator, electronic drive, and control unit ... ... Haydon Kerk Motion Solutions introduces the Haydon IDEA™ Drive stepper motor linear actuator. ...
... ... showcases the peak-season flavors of Texas citrus and pecans. Packed with healthy ingredients, this Italian-inspired, ... holidays not just for yourself, but everyone on your gift list. , ... Dallas, TX (PRWEB) November 11, 2009 -- Looking ...
... ... colorful Designer Hospital Gown prints, 251 Surgical Cap prints, Scrub Sacks, StethoSocks™, Medical Dental ... worldwide. , ... November 12, 2009 -- hospitalgowns.com and surgicalcaps.com launches its winter ...
... , ... is working with Terry White Chemists to provide better health outcomes for all Australians. ... (PRWEB) November ... and Australia’s leading pharmacy group are developing a strategic alliance that will give consumers ...
... ... recession businesses are under even more pressure to perform during the ... on businesses large and small over the coming months. While some ... viral medication for their employees, many medium and smaller businesses are ...
Cached Medicine News:Health News:Leukemia Drug May Help Some Ovarian Cancer Patients 2Health News:Haydon Kerk Motion Solutions Introduces the IDEA Drive 2Health News:Dip into a Healthy Holiday with the Taste of Texas Oncology's Holly Jolly Biscotti 2Health News:Dip into a Healthy Holiday with the Taste of Texas Oncology's Holly Jolly Biscotti 3Health News:Dip into a Healthy Holiday with the Taste of Texas Oncology's Holly Jolly Biscotti 4Health News:Surgicalcaps.com Introduces Surgical Scrub Sacks 2Health News:Surgicalcaps.com Introduces Surgical Scrub Sacks 3Health News:Medibank Private and Terry White Chemists to Form Partnership 2Health News:How to Survive Recession and Swine Flu Outbreak in Your Employees 2
(Date:6/30/2015)... , June 30, 2015  Marken, the leading clinical ... life sciences industry, has been granted permission by the ... of clinical drug product in Korea.  This precedent-setting shipment ... to continue receiving their clinical trial drugs ... The emergency was caused by recent partial ...
(Date:6/30/2015)... , June 30, 2015  Isis Pharmaceuticals, Inc. (NASDAQ: ... its 2015 Annual Meeting of StockholdersWhen:Tuesday, June 30 at ... on the Internet.  Simply log onto our website listed ... participate during the live event, a replay of the ... www.isispharm.com . ABOUT ISIS PHARMACEUTICALS, ...
(Date:6/29/2015)... Mordor Intelligence presents their Global Pharmaceutical Packaging ... Paper, Metal) - ByType of Packaging (Ampules, Blister Packs, Bottles, ... - By Geographical Region ( North America , ... , Latin America , Middle ... discussing Industry Value Chain Analysis, Porter,s 5 Force Analysis, Drivers, ...
Breaking Medicine Technology:Marken Delivers Direct To Patients During MERS Outbreak 2Marken Delivers Direct To Patients During MERS Outbreak 3Webcast Alert: Corporate Presentation at the 2015 Isis Pharmaceuticals Annual Stockholder Meeting 2Webcast Alert: Corporate Presentation at the 2015 Isis Pharmaceuticals Annual Stockholder Meeting 3Global Pharmaceutical Packaging Market - North America and Europe Expected to Lead Followed by the Asia Pacific Market 2Global Pharmaceutical Packaging Market - North America and Europe Expected to Lead Followed by the Asia Pacific Market 3
... magnification for advanced surgical procedures. Prismatic quality ... the highest magnification. 3.5x, 4.5x and 5.5x. ... rendition is ideal for surgical applications. Precision ... a superior image. The compact abd lightweight ...
... loupes are ideal for general dental ... and a large field of view ... aligned, lightweight and comfortable to wear ... and superior depth of focus means ...
... Left. 23 gauge thin wall ... Angled 20 degree shaft 10 mm ... set 0.5 mm behind aspiration tip. ... 46 cm (18.1 inches) of silicone ...
... stools come with five legs for extra ... 25" (total vertical travel 6"). 2" ball ... and fire retardant upholstery, available in black ... special order. Features a 16" x 14" ...
Medicine Products: